Abstract
THE purpose of this case report is to alert anesthesiologists and other medical and surgical staff as to the potential for increased postoperative bleeding in patients undergoing heart surgery after having received the recently introduced low-molecular-weight heparin preparations (e.g., enoxaparin) and new platelet inhibitors (e.g., tirofiban) in the setting of acute coronary syndromes or coronary interventional procedures.
Original language | English |
---|---|
Pages (from-to) | 869-872 |
Number of pages | 4 |
Journal | Anesthesiology |
Volume | 91 |
Issue number | 3 |
DOIs | |
State | Published - Sep 1999 |
Keywords
- Complications
- Low-molecular-weight heparin
- Platelet GP lIb/IlIa inhibitor